Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases
Mark A Rosenthal, Peter Davidson, Frederic Rolland, et al.
Journal of Advanced Research
|
October 9, 2025
Corrigendum to "Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction" Adv. Res. 69 (2025) 399-411]
Jiehuang Zheng, Weili He, Yan Chen, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Current Medical Research and Opinion
|
September 14, 2006
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial
Robert Recker, Paul Lips, Dieter Felsenberg, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive Designs
Eva Miller, Paul Gallo, Weili He, et al.
Neurological Research
|
December 4, 2020
Tirofiban combined with heparin's effect and safety in the treatment of mild to moderate acute ischemic stroke
Tao Qiu, Changqing Li, Linming Huang, et al.
Clinical and Translational Science
|
February 19, 2025
Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
Jie Chen, Junrui Di, Nadia Daizadeh, et al.
Journal of Clinical Pharmacology
|
August 20, 2004
Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans
Arthur J Bergman, Gail Murphy, Joanne Burke, et al.
Clinical Pharmacology and Therapeutics
|
March 13, 2025
Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Lei Nie, Shiowjen Lee, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Susan Gruber, Hana Lee, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Asia-Pacific Journal of Clinical Oncology
|
April 20, 2010
Evaluation of the safety, pharmacokinetics and treatment effects of an alpha(nu)beta(3) integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases
Mark A Rosenthal, Peter Davidson, Frederic Rolland, et al.
Journal of Advanced Research
|
October 9, 2025
Corrigendum to "Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction" Adv. Res. 69 (2025) 399-411]
Jiehuang Zheng, Weili He, Yan Chen, et al.
Journal of Advanced Research
|
March 31, 2024
Erianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction
Jiehuang Zheng, Weili He, Yan Chen, et al.
Current Medical Research and Opinion
|
September 14, 2006
Alendronate with and without cholecalciferol for osteoporosis: results of a 15-week randomized controlled trial
Robert Recker, Paul Lips, Dieter Felsenberg, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
DIA's Adaptive Design Scientific Working Group (ADSWG): Best Practices Case Studies for "Less Well-understood" Adaptive Designs
Eva Miller, Paul Gallo, Weili He, et al.
Neurological Research
|
December 4, 2020
Tirofiban combined with heparin's effect and safety in the treatment of mild to moderate acute ischemic stroke
Tao Qiu, Changqing Li, Linming Huang, et al.
Clinical and Translational Science
|
February 19, 2025
Decentralized Clinical Trials in the Era of Real-World Evidence: A Statistical Perspective
Jie Chen, Junrui Di, Nadia Daizadeh, et al.
Journal of Clinical Pharmacology
|
August 20, 2004
Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humans
Arthur J Bergman, Gail Murphy, Joanne Burke, et al.
Clinical Pharmacology and Therapeutics
|
March 13, 2025
Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Lei Nie, Shiowjen Lee, et al.
Clinical Pharmacology and Therapeutics
|
February 14, 2025
Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
Jie Chen, Susan Gruber, Hana Lee, et al.
Page
of 4